|
Market Closed -
Nasdaq
23:00:00 15/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 1.600 USD | -3.03% |
|
-15.34% | -76.57% |
| 09-10 | Transcode Therapeutics, Inc. Announces CFO Changes, Effective September 9, 2026 | CI |
| 09-10 | Transcode Therapeutics, Inc. Announces Management Changes, Effective from September 9, 2026 | CI |
| Market Cap | 27.94M 24.2M 22.88M 20.72M 38.88M 2.68B 39.17M 273M 105M 1.36B 105M 103M 4.33B | P/E 2024 |
-0.07x | P/E 2025 | -0.13x |
|---|---|---|---|---|---|
| Enterprise Value | 10.12M 8.77M 8.29M 7.51M 14.09M 971M 14.19M 98.94M 38.06M 492M 38.02M 37.18M 1.57B | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
98.22% | Yield 2024 * |
-
| Yield 2025 | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| RNAZ | Delayed | |
CBOE
| RNAZ | Real-time |
Last Transcript: TransCode Therapeutics, Inc.
| 1 day | -3.03% | ||
| 1 week | -15.34% | ||
| Current month | -23.81% | ||
| 1 month | -49.37% | ||
| 3 months | -70.75% | ||
| 6 months | -82.89% | ||
| Current year | -76.57% |
| 1 week | 1.6 |  | 1.95 |
| 1 month | 1.6 | | 3.5 |
| Current year | 1.6 | | 12.6 |
| 1 year | 1.6 | | 20.99 |
| 3 years | 1.6 | | 118,271.9 |
| 5 years | 1.6 | | 3,901,981.08 |
| 10 years | 1.6 | | 5,174,452.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Philippe Calais
CEO | Chief Executive Officer | 67 | 06/10/2025 |
Zdravka Medarova
CTO | Chief Tech/Sci/R&D Officer | 52 | 01/10/2021 |
John Tattory
DFI | Director of Finance/CFO | 61 | 10/09/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Philippe Calais
CHM | Chairman | 67 | 18/02/2021 |
Erik Manting
BRD | Director/Board Member | 54 | 20/12/2020 |
Magda Marquet
BRD | Director/Board Member | 67 | 01/01/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/9/26 A | Free | Chief Executive Officer | 185,000 | 1.0927% | ||
| 8/3/26 A | Conversion | Company | 13,834,441 | 81.7120% | ||
| 7/27/26 A | Other | Company | 300,040 | 1.7722% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.03% | -15.34% | -85.39% | -99.99% | 27.94M | |
| -1.38% | +2.23% | +48.54% | +100.96% | 70.24B | |
| -1.04% | -1.22% | +33.27% | +74.98% | 62.63B | |
| -4.29% | -3.98% | -16.22% | +350.66% | 27.36B | |
| +0.16% | +1.53% | +34.92% | +17.47% | 25.71B | |
| -2.20% | -2.00% | -1.22% | -14.48% | 24.83B | |
| +1.61% | +0.42% | +19.44% | -20.66% | 19.52B | |
| +1.26% | -9.06% | +165.21% | +308.08% | 15.51B | |
| -3.91% | -5.71% | -8.71% | +521.92% | 14.66B | |
| -5.54% | +0.69% | -8.13% | +830.48% | 14.69B | |
| Average | -1.84% | -3.19% | +18.17% | +206.94% | 27.52B | |
| Weighted average by Cap. | -1.52% | -0.65% | +31.29% | +166.07% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -16.75M -14.51M -13.72M -12.42M -23.32M -1.61B -23.49M -164M -63.01M -815M -62.94M -61.54M -2.6B | -34.66M -30.02M -28.39M -25.7M -48.24M -3.32B -48.6M -339M -130M -1.69B -130M -127M -5.38B |
| Net Debt | -5.77M -5M -4.73M -4.28M -8.03M -554M -8.09M -56.43M -21.71M -281M -21.68M -21.2M -895M | -17.81M -15.43M -14.59M -13.21M -24.79M -1.71B -24.98M -174M -66.99M -866M -66.91M -65.43M -2.76B |
Employees
12
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/09/26 | $1.600 | -3.03% | 16,551 |
| 14/09/26 | $1.650 | -2.37% | 20,663 |
| 11/09/26 | $1.690 | 0.00% | 11,445 |
| 10/09/26 | $1.690 | -5.06% | 26,085 |
| 09/09/26 | $1.780 | -5.82% | 30,939 |
Net sales - Rate of surprise
- Stock Market
- Stocks
- RNAZ Stock
Select your edition
All financial news and data tailored to specific country editions
